DNDominik Nann

Dominik Nann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dominik Nann has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Falko Fend

    Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany

    7 shared publications
  • Leticia Quintanilla-Martinez

    Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany

    5 shared publications
  • Vanessa Borgmann

    Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany

    4 shared publications
  • Franziska Otto

    Institute of Pathology and Neuropathology, University Hospital Tuebingen and Comprehensive Cancer Center, Tuebingen, Germany

    3 shared publications
  • Irina Bonzheim

    Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany

    3 shared publications
  • Irina Bonzheim

    Department of Pathology and Neuropathology University Hospital Tübingen Tübingen Germany

    3 shared publications

Latest Publications

  • Nodal marginal zone lymphoma: genetic analysis and the differential diagnosis from other small B-cell lymphomas

    by Vanessa Borgmann, Hannah Gierer, Stefanie Paigin, Antonio Vogelsberg, Jan Bosch-Schips, Barbara Mankel, Karl Sotlar, Matthias S. Dettmer, Irina Bonzheim, Falko Fend, et al.

    Nodal marginal zone lymphoma (NMZL) is a rare indolent B-cell lymphoma without a disease-defining phenotype. The distinction from other small B-cell lymphomas is challenging, especially from t(14;18)-negative follicular lymphoma (FL). To find out whether molecular analysis could help in separating NMZL from other small B-cell lymphomas, we analyzed a cohort of 52 patients with the diagnosis or differential diagnosis of NMZL using targeted next-generation sequencing and gene expression profiling (GEP). After morphological and mutational analysis, 38 (73%) patients were classified as NMZL, 8 (15%) patients as t(14;18)-negative FL, and 6 (12%) patients as chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical phenotype. The most frequently mutated gene in NMZL was KLF2 (34%), followed by KMT2D (21%) and TBL1XR1 (16%). Overall, the NF-κB pathway (13%), the NOTCH pathway (16%), and genes involved in chromatin remodeling and transcriptional regulation (55%) were frequently affected. Confirming the classification based on pathological and genetic features, GEP revealed distinct transcriptional profiles for NMZL and t(14;18)-negative FL. Although the latter group showed upregulation of genes associated with the germinal center and the interleukin-4 pathway, NMZL revealed upregulation of genes identified in memory B cells. In summary, despite showing genetic heterogeneity, NMZL is characterized by recurrent genetic alterations resulting in perturbations of specific pathways. These alterations, although not specific per se, render very characteristic genetic profiles, and when used in the context of other findings, are a useful adjunct to distinguish NMZL from other small B-cell lymphomas.

  • Open Access

    Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis

    by Dominik Nann, Tim‐Colin Schade, Mathis Overkamp, Lejla Mahmutovic, Eyyub Bag, Stephan Forchhammer, Julia Slotta‐Huspenina, Ludmila Boudova, Karl Sotlar, Leticia Quintanilla‐Martinez, et al.

    Myeloid sarcoma (MS) is a mass‐forming extramedullary manifestation of myeloid blasts, either in relation to an underlying acute myeloid leukemia (AML), another myeloid neoplasm (MN) or as a de novo occurrence. Data on the genetic profile of MS are sparse. In this study, 41 MS of 34 patients, including 7 de novo cases and 24 patients with antecedent or synchronous MN, were analyzed with targeted next‐generation sequencing (NGS), RNA‐based fusion detection, and gene expression profiling (GEP). In 10 patients, a MS developed after stem cell transplantation for MN. Additionally, 21 available pre‐transplant bone marrow biopsies (BMB) from 20 patients and 6 post‐transplant BMB from 6 patients were investigated. The most frequently mutated gene was TET2 (41%), followed by NPM1 (38%) and NRAS (35%). Overall, 74% of the cases exhibited mutations affecting the MAPK/ERK pathway. AML‐type fusions were detected in seven MS patients, who were younger than those without fusions (median 49 versus 67 years). Nine of 13 patients with a MN and available pre‐transplant BMB showed additional mutations restricted to the MS, including an additional NRAS mutation in 3/5 cases with AML. Five of seven of patients with pre‐transplant BMB without evidence of a MN revealed clonal hematopoiesis (CH), mostly shared TET2 mutations. Comparative GEP between BM and MS revealed upregulation of the MAPK/ERK pathway in MS and of gene sets relevant for interaction with the microenvironment. In conclusion, MS is characterized by a high incidence of MAPK/ERK pathway mutations and activation, frequent clonal evolution, and association with CH in elderly patients without recurrent AML‐type fusions.


  • Open Access

    Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type

    by Lennart Harland, Vanessa Borgmann, Franziska Otto, Mathis Overkamp, Irina Bonzheim, Falko Fend, Leticia Quintanilla-Martinez, Dominik Nann


  • Open Access

    Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T‐cell lymphoma and angioimmunoblastic T‐cell lymphoma

    by Antonio Vogelsberg, Lennart Harland, Vanessa Borgmann, Franziska Otto, Jan F. Weller, Dominik Nann, Leticia Quintanilla‐Martinez, Falko Fend

    Summary: Recent studies have shown that follicular helper T‐cell lymphoma of angioimmunoblastic type (AITL), the most common nodal peripheral T‐cell lymphoma (PTCL), frequently arises in a background of clonal haematopoiesis (CH), a preneoplastic condition affecting up to 40% of elderly individuals. Data on a potential CH association are limited for other PTCL. We report a unique patient who sequentially developed both cytotoxic PTCL, not otherwise specified and AITL with distinct T‐cell receptor rearrangements but shared somatic mutations originating from the same CH clone, thus providing convincing evidence that CH can give rise to T‐cell neoplasms of different lineage.


  • Open Access

    Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution—a proof of principle study

    by Dominik Nann, Achim Rau, Lejla Mahmutovic, Julia Steinhilber, Vanessa Meca, Birgit Federmann, Wichard Vogel, Irina Bonzheim, Leticia Quintanilla-Martinez, Falko Fend

    Differential diagnosis of clonal versus reactive cytopenia and monocytosis, respectively, frequently presents a diagnostic challenge. With the two recent classifications of myeloid disorders, mutational analysis has gained importance as a diagnostic tool. However, reports on its utility on trephine bone marrow biopsies (BMB) are sparse. The aim of our proof of principle study was to determine the suitability of targeted sequencing for the longitudinal evaluation of cytopenia and monocytosis and demonstration of clonal evolution on sequential BMB. Seventy-seven EDTA-decalcified BMB of 33 patients with peripheral cytopenia and/or monocytosis, including at least one follow-up biopsy/patient, were included. Initial morphological diagnoses were idiopathic cytopenia of undetermined significance (ICUS, 8 cases), MDS (without blast increase, 7 cases), MDS with increased blasts/excess blasts (MDS-IB/EB) (11 cases), and CMML (7 cases). Thirty-one genes relevant for myeloid disorders were examined using two custom AmpliSeq NGS panels. Mutations were found in the initial BMB of 5/8 cases of ICUS, thus changing the diagnosis to clonal cytopenia of unknown significance (CCUS), 5/7 MDS, 10/11 MDS-IB/EB, and 7/7 CMML. Clonal evolution was observed in 14/33 (42%) cases, mostly associated with disease progression. None of the wild-type patients acquired mutations during follow-up. NGS-based mutation profiling is a robust diagnostic tool for BMB and provides valuable additional information, especially for cases with no/minimal dysplasia, and for better risk stratification of MDS. Tracking variant allele frequency and appearance of mutations over time allows for observing clonal evolution or relapse.


  • Open Access

    A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

    by Julia Salmeron-Villalobos, Caoimhe Egan, Vanessa Borgmann, Inga Müller, Blanca Gonzalez-Farre, Joan Enric Ramis-Zaldivar, Dominik Nann, Olga Balagué, Mónica López-Guerra, Dolors Colomer, et al.

    Pediatric nodal marginal zone lymphoma (PNMZL) is an uncommon B-cell neoplasm affecting mainly male children and young adults. This indolent lymphoma has distinct characteristics that differ from those of conventional nodal marginal zone lymphoma (NMZL). Clinically, it exhibits overlapping features with pediatric-type follicular lymphoma (PTFL). To explore the differences between PNMZL and adult NMZL and its relationship to PTFL, a series of 45 PNMZL cases were characterized morphologically and genetically by using an integrated approach; this approach included whole-exome sequencing in a subset of cases, targeted next-generation sequencing, and copy number and DNA methylation arrays. Fourteen cases (31%) were diagnosed as PNMZL, and 31 cases (69%) showed overlapping histologic features between PNMZL and PTFL, including a minor component of residual serpiginous germinal centers reminiscent of PTFL and a dominant interfollicular B-cell component characteristic of PNMZL. All cases displayed low genomic complexity (1.2 alterations per case) with recurrent 1p36/TNFRSF14 copy number–neutral loss of heterozygosity alterations and copy number loss (11%). Similar to PTFL, the most frequently mutated genes in PNMZL were MAP2K1 (42%), TNFRSF14 (36%), and IRF8 (34%). DNA methylation analysis revealed no major differences between PTFL and PNMZL. Genetic alterations typically seen in conventional NMZL were absent in PNMZL. In summary, overlapping clinical, morphologic, and molecular findings (including low genetic complexity; recurrent alterations in MAP2K1, TNFRSF14, and IRF8; and similar methylation profiles) indicate that PNMZL and PTFL are likely part of a single disease with variation in the histologic spectrum. The term “pediatric-type follicular lymphoma with and without marginal zone differentiation” is suggested.


  • Open Access

    Forecasting the future number of pertussis cases using data from Google Trends

    by Dominik Nann, Mark Walker, Leonie Frauenfeld, Tamás Ferenci, Mihály Sulyok


  • Open Access

    Small lymphocytic leukemia with herpes simplex virus infection simulating metastatic cancer

    by Sven Mattern, Dominik Nann

    Sven Mattern, Dominik Nann; Small lymphocytic leukemia with herpes simplex virus infection simulating metastatic cancer, Blood, Volume 136, Issue 26, 24 Decembe

  • Open Access

    Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease

    by Dominik Nann, Joan Enric Ramis-Zaldivar, Inga Müller, Blanca Gonzalez-Farre, Janine Schmidt, Caoimhe Egan, Julia Salmeron-Villalobos, Guillem Clot, Sven Mattern, Franziska Otto, et al.

    Fifty-five cases of t(14;18)− follicular lymphoma (FL) were genetically characterized by targeted sequencing and copy number (CN) arrays. t(14;18)− FL predominated in women (M/F 1:2); patients often presented during early clinical stages (71%), and had excellent prognoses. Overall, t(14;18)− FL displayed CN alterations (CNAs) and gene mutations carried by conventional t(14;18)+ FL (cFL), but with different frequencies. The most frequently mutated gene was STAT6 (57%) followed by CREBBP (49%), TNFRSF14 (39%), and KMT2D (27%). t(14;18)− FL showed significantly more STAT6 mutations and lacked MYD88, NOTCH2, MEF2B, and MAP2K1 mutations compared with cFL, nodal marginal zone lymphoma (NMZL), and pediatric-type FL (PTFL). We identified 2 molecular clusters. Cluster A was characterized by TNFRSF14 mutations/1p36 alterations (96%) and frequent mutations in epigenetic regulators, with recurrent loss of 6q21-24 sharing many features with cFL. Cluster B showed few genetic alterations; however, a subgroup with STAT6 mutations concurrent with CREBBP mutations/16p alterations without TNFRSF14 and EZH2 mutations was noted (65%). These 2 molecular clusters did not distinguish cases by inguinal localization, growth pattern, or presence of STAT6 mutations. BCL6 rearrangements were demonstrated in 10 of 45 (22%) cases and did not cluster together. Cases with predominantly inguinal presentation (20 of 50; 40%) had a higher frequency of diffuse growth pattern, STAT6 mutations, CD23 expression, and a lower number of CNAs, in comparison with noninguinal cases (5.1 vs 9.1 alterations per case; P < .05). STAT6 mutations showed a positive correlation with CD23 expression (P < .001). In summary, t(14;18)− FL is genetically a heterogeneous disorder with features that differ from cFL, NMZL, and PTFL.